Dublin–(business wire)–“Blockchain Technology in Healthcare Market: Distribution by Blockchain Types, End-User Types, and Major Geographic Regions: Industry Trends and Global Forecast, 2023-2035” report added of ResearchAndMarkets.com Recruitment.
This report features extensive research into the current market status and future potential of blockchain in drug discovery and clinical trials. The report highlights the efforts of multiple stakeholders involved in this rapidly emerging segment of the pharmaceutical industry and answers many important questions related to this area.
What are the future possibilities of blockchain in healthcare?
The popularity of blockchain technology has been steadily increasing over the last few years. This technology has the potential to revolutionize the healthcare sector as it emerges as a viable option for storing/exchanging data within the healthcare industry.
Additionally, in addition to compiling long-term patient records such as disease registries, laboratory results, and treatment-related data records, there is a greater need for tracking and authenticating medical shipments/pharmaceuticals throughout the supply chain and during logistical operations. We provide fast solutions.
Which pharmaceutical companies are using blockchain?
Examples of pharmaceutical companies using blockchain include (in alphabetical order) Amgen, Novartis, Pfizer, and Sanofi.
What is the current market status of the blockchain market focused on drug discovery and clinical trials?
Various types of blockchain platforms, such as public blockchain, private blockchain, and consortium blockchain, are currently used in various drug development applications such as drug discovery, intellectual property management, electronic medical record management, vaccine distribution, and drug authenticity ( DDA) is used. Pharmaceutical supply chain, pharmaceutical data management, clinical trial management, and electronic signatures. It is worth noting that over 50 blockchain providers offer their own platforms for these applications across industries such as healthcare, pharmaceuticals and government agencies.
What are the key value drivers of the blockchain market in drug discovery and clinical trials?
In recent years, the use of blockchain has increased, driven by several technological advances and the growing demand for safe and secure methods of patient recruitment, retention and data management in drug discovery and clinical trials. It is worth mentioning that the use of blockchain technology in drug discovery operations is expected to improve the entire drug development process by enabling traceability and identification of counterfeit and counterfeit drugs in the drug supply chain.
What are the key advantages offered by new blockchain platforms in drug discovery and clinical trials?
In recent years, there has been an increase in the use of blockchain technology in healthcare, especially in drug discovery and clinical trial management. This may be due to the fact that blockchain offers a faster solution for tracking and authenticating drugs/pharmaceuticals throughout the supply chain. Additionally, clinical trial data can be stored securely via a blockchain platform/portal. Additionally, the technology will allow patients to access their own medical data and ensure that such data will only be shared with the owner’s permission.
What are the key trends of blockchain in the drug discovery and clinical trials market?
It is noteworthy that over 500 research papers in this field have been published in high-impact journals over the past six years, underscoring the tremendous efforts of researchers. The majority of these publications are research articles focused on evaluating the use of blockchain across pharmaceutical supply chain and clinical trial management.
What is the market size of blockchain in the drug discovery and clinical trials market?
As adoption of blockchain, especially for drug development applications, increases among innovators in the pharmaceutical and biopharmaceutical industries, it is expected to create lucrative opportunities for players involved in blockchain for drug discovery and clinical trials markets. . Focused on drug discovery and clinical trials, the blockchain market is expected to grow at a healthy rate of over 22% over the next decade. This opportunity is likely to be well spread across different types of blockchains, end-user types, and major geographic regions.
Who Are the Key Players of Blockchain in the Drug Discovery and Clinical Trials Market?
Examples of major players involved in this domain (also featured in this report) include (in alphabetical order) Alten Calsoft Labs, ConsenSys, IBM, Infosys, Stratumn, and Tech Mahindra.
Frequently Asked Questions
question 1: What is the growth rate of the blockchain market centered on drug discovery and clinical trials?
Answer: The blockchain market focused on drug discovery and clinical trials is expected to grow at an annual rate of 22% between 2023 and 2035.
Question 2: Which region will lead the blockchain market focused on drug discovery and clinical trials?
Answer: North America and Asia Pacific are expected to capture more than 65% of the market share by 2035. The European market is likely to grow at a relatively fast pace in the long term.
Question 3: In terms of blockchain type, which segment dominates the blockchain market focused on drug discovery and clinical trials?
A: Currently, private blockchains dominate the blockchain market in drug discovery and clinical trials. However, public blockchains are expected to drive the market in the near future.
Question 4: In the blockchain market focused on drug discovery and clinical trials, which segment has the largest share in terms of end-user types?
Answer: The pharmaceutical industry and academic institutions are expected to capture approximately 60% of the market share by 2035. Additionally, the hospital market is likely to grow at a relatively fast pace in the long term.
Question 5: What partnership models are most commonly employed by stakeholders working in this space?
Answer: Platform usage has emerged as the most popular type of partnership model adopted by players providing blockchain in drug discovery and clinical trials. This will be followed by platform integration agreements and strategic alliances.
Main topics:
1. Preface
2. Executive Summary
3. Introduction
4. Market overview
4.1. Chapter overview
4.2. Blockchain Technology Providers: Overall Market Outlook
5. Corporate Competitiveness Analysis
6. Company Profile
7. PARTNERSHIP AND COLLABORATION
8. Analysis of publications
9. SWOT analysis
9.1. Chapter overview
9.2. Blockchain in Drug Discovery and Clinical Trials: A SWOT Analysis
9.3. Comparing SWOT Elements
9.3.1. Strengths
9.3.1.1. Transparency and traceability
9.3.1.2. Cost savings and data integrity
9.3.1.3. Safe and secure transactions
9.3.1.4. Patient Data Management
9.3.2. Weaknesses
9.3.2.1. Implementation costs
9.3.2.2. Storage
9.3.2.3. Data immutability
9.3.2.4. High energy consumption
9.3.3. Threats
9.3.3.1. Blockchain is vulnerable to cyberattacks
9.3.3.2. Scalability
9.3.3.3. Lack of Regulations Issued by Legal Bodies
9.3.4. Opportunities
10. Case Studies: Blockchain Applications in Healthcare and Other Industries
11. Market forecast and opportunity analysis
12. Conclusion
13. Executive Insights
14. Appendix 1: Aggregated Data
15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
For more information on this report, please visit https://www.researchandmarkets.com/r/jh5sch.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. It provides up-to-date data on international and regional markets, key industries, top companies, new products and latest trends.
